Suggestions

Du même auteur

Interim PET after 4 Cycles Predicts Outcome in Histomolecularly Confirmed Primary Mediastinal B-Cell Lymphoma

Archive ouverte | Camus, Vincent | CCSD

International audience. The GAINED study (NCT01659099) was a randomized phase 3 trial comparing obinutuzumab (G) to rituximab (R) plus ACVBP or CHOP14 induction, followed by PET-guided consolidation. This post-hoc a...

Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA

Archive ouverte | Le Gouill, Steven | CCSD

International audience. Rituximab plus polychemotherapy is the standard of care in diffuse large B-cell lymphoma (DLBCL). GAINED, a randomized phase 3 trial, compared obinutuzumab to rituximab. Transplant-eligible p...

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Archive ouverte | Le Gouill, Steven | CCSD

International audience

Chargement des enrichissements...